Latest Edition Highlights (Issue 39)

Featured articles from our most recent publication

FROM AIR FORCE TO HYPERSONIC FUTURE: ÉLCIO GERÔNIMO DE OLIVEIRA'S JOURNEY IN BRAZILIAN AEROSPACE DEVELOPMENT (ENGLISH VERSION)

Introdução: A entrevista com Élcio Gerônimo de Oliveira, conduzida pelo repórter Luis, apresenta a trajetória profissional de um pesquisador brasileiro com experiência na Força Aérea Brasileira e no meio acadêmico, com foco em sistemas espaciais e veículos hipersônicos. Objetivos: Documentar a carreira e contribuições de Élcio para o desenvolvimento aeroespacial brasileiro, destacando sua transição da carreira militar para a acadêmica e sua participação em projetos estratégicos, especialmente o projeto 14X. Métodos: A entrevista foi estruturada em blocos temáticos, abordando a carreira militar, a experiência acadêmica e, com maior detalhamento, o envolvimento no projeto do veículo hipersônico 14X. Foram realizadas perguntas abertas, permitindo ao entrevistado compartilhar sua experiência e conhecimento técnico. Resultados: Élcio descreveu sua progressão na Força Aérea Brasileira, desde pesquisador até vice-chefe da Diretoria de Espaço, destacando o desenvolvimento de veículos lançadores, sistemas de navegação inercial e o projeto SARA. Relatou sua transição para a carreira acadêmica, incluindo sua experiência como professor na Universidade de Luleå, na Suécia. Élcio detalhou sua coordenação no projeto 14X, um veículo hipersônico que alcançou Mach 7, com perspectivas de atingir Mach 10. Discussão: A entrevista revela a importância da cooperação internacional e da transferência de tecnologia, exemplificada pela doação do primeiro laboratório de hipersônica do Brasil. Evidencia também os desafios técnicos na construção de veículos hipersônicos e o potencial dessas tecnologias para aplicações militares e civis. Conclusão: A carreira de Élcio Gerônimo de Oliveira exemplifica a contribuição brasileira para pesquisa aeroespacial avançada, demonstrando a capacidade nacional de desenvolver tecnologias estratégicas como veículos hipersônicos, apesar das limitações de recursos, e apontando possibilidades futuras para o transporte e exploração espacial.
Read Article

DETECTION OF EPSTEIN-BARR VIRUS (EBV) IN WOMEN WITH BREAST CANCER IN IRAQ USING IN-SITU HYBRIDIZATION AND IMMUNOHISTOCHEMICAL TECHNIQUES

Background: The Epstein-Barr virus (EBV) has recently been identified in human breast cancer globally, potentially contributing to the initiation and progression of this malignancy, as well as gastric cancer, nasopharyngeal carcinoma, and bladder cancer. It has been newly associated with breast cancer. Globally, breast cancer affects more women than any other type of cancer. In Iraq, the prevalence of breast cancer is comparable. Aims: The study examined Iraqi women diagnosed with invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) to detect Epstein-Barr Virus Nuclear Antigen-1 (EBNA-1) and encoded RNA (EBER). Methods: A total of 50 formalin-fixed paraffin-embedded tissues from invasive ductal carcinoma (IDC) (92%) and invasive lobular carcinoma (ILC) (8%) biopsy samples constituted the case group, while 30 formalin-fixed paraffin-embedded tissues from non-cancerous breast tissue served as the control group. The presence of Epstein-Barr virus protein (EBER) in breast tissue was assessed using immunohistochemistry (IHC) and chromogenic in situ hybridization (CISH) methods. Results: EBER RNA signals were found in 31 (62%). EBER RNA signals were seen in 3 (10%) control group participants. Significant differences (P<0.04) were seen in EBV EBER RNA positive signals among study groups. Immunohistochemistry showed nuclear brown staining in 34 (68%) breast cancer patients. Control group: 3 (10%). Discussion: The research identified a statistically significant correlation between EBV positivity and breast cancer among Iraqi women, especially concerning invasive ductal carcinoma. The results corroborate previous reports of elevated EBV levels in malignant breast tissues relative to controls. Although detection approaches such as CISH and IHC provide complementary insights, additional studies are needed. Conclusions: The study concludes that EBNA-1 and EBV EBER RNA were overexpressed in our population group.
Read Article

TREATMENTS FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A COMPARISON BETWEEN TISAGENLECLEUCEL AND CLOFARABINE

Background: Acute lymphoblastic leukemia (ALL) is a heterogeneous hematological malignancy predominantly affecting individuals under 20 years of age. Traditional chemotherapy, such as clofarabine, has shown efficacy; however, novel immunotherapeutic strategies like tisagenlecleucel (Kymriah®) have significantly altered the treatment paradigm. Aim: This study aimed to perform a comparative analysis of tisagenlecleucel, a CAR-T cell therapy, and clofarabine, a second-generation purine nucleoside analog, evaluating their mechanisms of action, therapeutic benefits, limitations, and clinical applicability across diverse patient populations. Methods: A systematic comparative evaluation was conducted, encompassing pharmacological characteristics, mechanisms of action, treatment protocols, efficacy, safety profiles, and clinical indications of both agents. The analysis considered pharmacokinetic and pharmacodynamic data and included patient demographic variables. Results: Tisagenlecleucel demonstrated high efficacy in refractory B-cell ALL, with durable responses and a blood half-life of 128 days, but with notable immune-related adverse effects such as cytokine release syndrome. Clofarabine, effective across a broader patient population, acts via multiple antitumor mechanisms but carries significant toxicity risks, including infection and sepsis. Discussion: The therapies present distinct clinical profiles: tisagenlecleucel offers targeted immunotherapy with high specificity but requires specialized infrastructure and management of immune toxicities. Clofarabine is more widely accessible and applicable, but is associated with conventional chemotherapy-related side effects. Treatment accessibility and cost differ markedly between the two. Conclusions: Therapy selection should be personalized based on patient-specific factors and institutional resources. Tisagenlecleucel is ideal for pediatric and young adult patients with relapsed/refractory B-cell ALL in CAR-T-capable centers, while clofarabine remains a viable option for broader ALL populations, particularly when genetic therapies are not feasible. Further research is needed to optimize therapeutic strategies and improve access to advanced treatments.
Read Article

General information

SOUTHERN JOURNAL OF SCIENCES

    General information about this journal
  • Title: SOUTHERN JOURNAL OF SCIENCES
  • Short Title: South. J. Sci.
  • ISSN: 2764-5959 (Online); ISSN: 2764-5967 (Print)
  • Universal Decimal Classification (UDC): 001
  • Review Process: Double-Blind Peer-Review
  • Accessibility: Platinum Open Access, NO-APCs.
  • Digital preservation: Portico
  • Frequency of Publication: biannual [2 issues per year]. Journal publication schedule
  • DOI: 10.48141/2764-5959
  • Website: https://www.sjofsciences.com/
  • Country: BRAZIL
  • Publisher: Araucária - Scientific Association.
  • Language of Publication: ENGLISH / PORTUGUESE*
  • *Year that the Journal started accepting manuscripts in Portuguese: 2020
  • First issue year: 1993
  • Free full text: Yes
  • Indexed in: Index Copernicus; Latindex, and I2OR.
  • Formerly known as the Southern Brazilian Journal of Chemistry (1993 to 2021).
  • Former ISSN: 2674-6891 (Online); Former ISSN: 0104-5431 (Print).
  • Website last update: 06/07/2025.

Journal last cover


Last Cover

DOWNLOAD

Selected Articles for Additional Reading (2018 - Present)

Discover more great content from our archive

FERRAMENTA DE ANONIMIZAÇÃO DE DADOS MÉDICOS COM PRESERVAÇÃO DE PRIVACIDADE

Background: Medical institutions collect a vast amount of sensitive patient data for personalized treatments and health trend analysis. However, this raises concerns regarding the privacy of patient data, as it contains sensitive and confidential information. Aims: Develop an anonymization tool using diverse techniques to protect data while preserving its utility. Methods: A Python-based data anonymization tool for medical datasets supporting both categorical and numerical data is developed. It employs various methods, including data perturbation, binning, scaling, transformation, and differential privacy. Results: The tool was able to anonymize sensitive data, both categorical and numerical, while preserving its utility for further analysis. Discussion: The Privacy-Preserving Data Anonymization Tool advances sensitive medical data management by anonymizing both categorical and numerical data using various techniques while retaining data utility. Conclusions: The Anonymization Tool addresses patient data privacy concerns by balancing data utility with privacy, enabling secure medical data use in research.
Read Article

ADSORPTION STUDIES OF ZINC, COPPER, AND LEAD IONS FROM PHARMACEUTICAL WASTEWATER ONTO SILVER-MODIFIED CLAY ADSORBENT

Background: Industrial wastewater contains pollutants that are detrimental to human health in varied proportions. Among the pollutants are heavy metals, including Zn2+, Pb2+, and Cu2+ found in a characterized pharmaceutical wastewater. Several techniques have been proposed for the heavy metal sequester. However, they are with attendant challenges. The adsorption techniques using clay-metal oxide modified adsorbent/composite such as silver-clay adsorbent is considered suitable for an effective sequestering process. Aims: To develop and characterize Ag/clay adsorbent for pharmaceutical wastewater treatment. Methods: The Ag nanoparticles were synthesized using Parkia biglobossa aqueous leaves extract in an optimization study. The raw clay was beneficiated and doped with silver nanoparticles via the wet impregnation method. The silver-clay adsorbent was characterized using FTIR, XRD, SEM, and EDS characterization tools. The developed adsorbent was used for the batch adsorption process of the heavy metal ion removal from the wastewater. Results and Discussion: The phytochemical analysis and FTIR results of the P. biglobosa showed that the leaf contains phenol, tannin, and flavonoids which acts as reducing, capping, and stabilizing agent required for synthesizing the silver nanoparticles. The prepared silver nanoparticles modified clay adsorbent Ag/clay, have evenly distributed stacks of pseudo-hexagonal plates, are rich in silica, possess silver nanoparticles in the frameworks, and contain functional groups suitable for binding heavy metals. The adsorptions of Zn2+, Pb2+, and Cu2+ from pharmaceutical wastewater onto the silver-modified clay were studied as a function of adsorbent dosage and contact time. The percentage removal results obtained showed that the adsorbent had up to 99.96%, 99.5%, and 99.44% removal efficiency for Zn2+, Pb2+, and Cu2+, respectively, which are better compared with previous studies. The adsorption process was feasible, spontaneous, and exothermic, with Langmuir and Pseudo-second-order models as best fits for the process. Conclusions: The adsorption of selected heavy metal ions onto the green synthesized silver-modified clay adsorbent (Ag/clay) was feasible, spontaneous, and exothermic in the order Zn2+>Pb2+>Cu2+ with Langmuir and Pseudo-second-order model best fitted for the process. These show that the synthesized silver oxide nanoparticles supported on local clay can be used as a potentially low-cost adsorbent to remove heavy metal ions from industrial wastewater.
Read Article

SOUTHERN JOURNAL OF SCIENCES ANNUAL TRANSPARENCY REPORT

ATR 2023. SOUTHERN JOURNAL OF SCIENCES ANNUAL TRANSPARENCY REPORT.
Read Article

Other relevant news

SOUTHERN JOURNAL OF SCIENCES

The SOUTHERN JOURNAL OF SCIENCES publishes articles in Chemistry, Physics, Mathematics, Biology, Pharmacy, Medicine, Engineering, Industrial Science, Agriculture, and related interdisciplinary areas and is intended to fill a gap in terms of scientific information worldwide. All manuscripts can be published either in English or Portuguese, with tile, abstracts, and keywords in English. At present, there are NO PUBLICATION FEES. Editors will cover web hosting, open access, DOI number, and other service costs.

We have set high standards for the articles to be published by ensuring strong but fair refereeing by at least two reviewers. We hope that this Journal will provide a forum for disseminating high-quality research in chemistry and related areas and are open to any questions and suggestions. Starting in 2020, the SOUTHERN JOURNAL OF SCIENCES will have two issues per year (June and December).

Thank you very much for choosing the SOUTHERN JOURNAL OF SCIENCES to publish your paper!
Editorial Team

THANK YOU FOR YOUR PRESENCE


It was an honor the have you with us.

Last Cover

Crossref Content Registration logo
Portico logo